MedPath

Brevibloc

These highlights do not include all the information needed to use BREVIBLOC injection safely and effectively. See full prescribing information for BREVIBLOC injection.BREVIBLOC (Esmolol Hydrochloride) injection, for intravenous use Initial U.S. Approval: 1986

Approved
Approval ID

595cc3d5-1306-4828-aefa-5595219ffd62

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 15, 2023

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Esmolol Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10019-115
Application NumberNDA019386
Product Classification
M
Marketing Category
C73594
G
Generic Name
Esmolol Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 1, 2014
FDA Product Classification

INGREDIENTS (7)

ESMOLOL HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: V05260LC8D
Classification: ACTIB
SODIUM ACETATEInactive
Quantity: 2.8 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDInactive
Quantity: 0.546 mg in 1 mL
Code: Q40Q9N063P
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 5.9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

Esmolol Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10019-075
Application NumberNDA019386
Product Classification
M
Marketing Category
C73594
G
Generic Name
Esmolol Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 1, 2014
FDA Product Classification

INGREDIENTS (7)

SODIUM ACETATEInactive
Quantity: 2.8 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ESMOLOL HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V05260LC8D
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 4.1 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
ACETIC ACIDInactive
Quantity: 0.546 mg in 1 mL
Code: Q40Q9N063P
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Esmolol Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10019-055
Application NumberNDA019386
Product Classification
M
Marketing Category
C73594
G
Generic Name
Esmolol Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 1, 2014
FDA Product Classification

INGREDIENTS (7)

SODIUM ACETATEInactive
Quantity: 2.8 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ESMOLOL HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: V05260LC8D
Classification: ACTIB
ACETIC ACIDInactive
Quantity: 0.546 mg in 1 mL
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 5.9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Brevibloc - FDA Drug Approval Details